Homecare, smiling male physician/prescriber in physician‘s office/hospital talking to female Linde sales rep, information, consulting

Κλινική τεκμηρίωση

Στόχος μας είναι να δημιουργήσουμε ισχυρές συνεργασίες εμπιστοσύνης με τους κλινικούς ιατρούς και νοσηλευτές, να τους βοηθήσουμε στη διαχείριση των ασθενών τους και την όσο το δυνατόν αποτελεσματικότερη αξιοποίηση των πόρων τους.

Κοινοποιούμε συχνά απόψεις και έρευνες για να ενθαρρύνουμε την καλή πρακτική.

Ακολουθεί μια επιλογή από χρήσιμες παραπομπές:

Μη επεμβατικός μηχανικός αερισμός θετικής πίεσης (ΜΕΜΑ)
Υπνική άπνοια

Additional information and relevant references:

Chronic Obstructive Pulmonary Disease (COPD)
  • World Health Organization: Chronic Respiratory Diseases. (read)
  • Mathers, C., Fat, D. M., & Boerma, J. T. (2008). The global burden of disease: 2004 update. World Health Organization. (read)
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD): Pocket guide to COPD diagnosis, management and prevention. (read)
  • Wier, L. M., Elixhauser, A., Pfuntner, A., & Au, D. H. (2006). Overview of hospitalizations among patients with COPD, 2008: Statistical Brief# 106. (read)
  • Stoller, J. K., Panos, R. J., Krachman, S., Doherty, D. E., & Make, B. (2010). Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. CHEST Journal, 138(1), 179-187.
  • Köhnlein T. et al. (2014). Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. The Lancet Respiratory medicine, 2(9), 698-705.
  • Ford, E. S., Murphy, L. B., Khavjou, O., Giles, W. H., Holt, J. B., & Croft, J. B. (2015). Total and state-specific medical and absenteeism costs of COPD among adults aged≥ 18 years in the United States for 2010 and projections through 2020. Chest Journal, 147(1), 31-45.
  • Guarascio, A. J., Ray, S. M., Finch, C. K., & Self, T. H. (2013). The clinical and economic burden of chronic obstructive pulmonary disease in the USA. ClinicoEconomics and outcomes research: CEOR, 5, 235-245.
Hypoxia and Long Term Oxygen Therapy (LTOT)
  • World Health Organization. (read)
  • European COPD Coalition. Key facts. (read)
  • Górecka, D., Gorzelak, K., Sliwiński, P., Tobiasz, M., & Zieliński, J. (1997). Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax, 52(8), 674-679.
  • Hardinge, M., Suntharalingam, J., & Wilkinson, T. (2015). Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults. Thorax, thoraxjnl-2015.
  • Oba, Y. (2009). Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease. The American journal of managed care, 15(2), 97-104.
  • Reisfield, G. M., & Wilson, G. R. (2004). The cost of breathing: an economic analysis of the patient cost of home oxygen therapy. American Journal of Hospice and Palliative Medicine®, 21(5), 348-352.
  • Stoller, J. K., Panos, R. J., Krachman, S., Doherty, D. E., & Make, B. (2010). Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. CHEST Journal, 138(1), 179-187.
  • Young, R. P., Hopkins, R. J., Christmas, T., Black, P. N., Metcalf, P., & Gamble, G. D. (2009). COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. European Respiratory Journal, 34(2), 380-386.
Non-Invasive Positive Pressure Ventilation (NPPV)
  • Köhnlein, T. et al. (2014). Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. The Lancet Respiratory medicine, 2(9), 698-705. (read)